LiveRamp (NYSE:RAMP) Receives Buy Rating from Benchmark

Benchmark reissued their buy rating on shares of LiveRamp (NYSE:RAMP – Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a $56.00 price objective on the stock. Several other equities analysts have also issued reports on RAMP. StockNews.com upgraded shares of LiveRamp from a buy rating to a strong-buy […]

Leave a Reply

Your email address will not be published.

Previous post Teva Pharmaceutical Industries (NYSE:TEVA) Upgraded by Argus to “Buy”
Next post Baseball All-Scholastics and league All-Stars